Rockefeller Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-56
| Closed | -$19K | – | 2234 |
|
|
2022
Q4 | $19K | Hold |
56
| – | – | ﹤0.01% | 2818 |
|
|
2022
Q3 | $10K | Hold |
56
| – | – | ﹤0.01% | 3072 |
|
|
2022
Q2 | $11K | Sell |
56
-69
| -55% | -$13.6K | ﹤0.01% | 3053 |
|
|
2022
Q1 | $41K | Hold |
125
| – | – | ﹤0.01% | 2384 |
|
|
2021
Q4 | $40K | Hold |
125
| – | – | ﹤0.01% | 2315 |
|
|
2021
Q3 | $60K | Buy |
125
+69
| +123% | +$33.1K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $26K | Hold |
56
| – | – | ﹤0.01% | 2366 |
|
|
2021
Q1 | $38K | Hold |
56
| – | – | ﹤0.01% | 2003 |
|
|
2020
Q4 | $41K | Hold |
56
| – | – | ﹤0.01% | 1739 |
|
|
2020
Q3 | $39K | Sell |
56
-7
| -11% | -$4.88K | ﹤0.01% | 1578 |
|
|
2020
Q2 | $53K | Buy |
+63
| New | +$53K | ﹤0.01% | 1394 |
|